+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Spontaneous and induced tolerance for liver transplant recipients



Spontaneous and induced tolerance for liver transplant recipients



Current Opinion in Organ Transplantation 21(1): 53-58



Transformative medical and surgical advances have remarkably improved short-term survival after liver transplantation. There is, however, pervasive concern that the cumulative toxicities of modern immunosuppression regimens severely compromise both quality and quantity of life for liver transplant recipients. The inherently tolerogenic nature of the liver offers the tantalizing opportunity to change the current paradigm of nonspecific and lifelong immunosuppression. Safe minimization or discontinuation of immunosuppression without damage to the liver allograft is an attractive strategy to improve long-term survival after liver transplantation. Recent prospective, multicenter clinical trials have demonstrated that immunosuppression can be safely withdrawn from selected liver transplant recipients with preservation of allograft histology. These successes have spurred multiple avenues of investigation to identify peripheral blood and/or tissue biomarkers and delineate mechanisms of tolerance. Concomitant advances in the ability to expand regulatory T cells in the laboratory have spawned clinical trials to facilitate immunosuppression minimization and/or discontinuation. This review will delineate the unique liver immunobiology that has driven the recent clinical trials to unmask spontaneous tolerance or induce tolerance for liver transplant recipients. The emerging results of these trials over the next 5 years hold promise to reduce the burden of lifelong immunosuppression and thereby optimize the long-term health of liver transplant recipients.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 058891995

Download citation: RISBibTeXText

PMID: 26709575

DOI: 10.1097/mot.0000000000000268


Related references

In vitro correlates of transplant tolerance A preliminary study in liver transplant recipients. Human Immunology 62(Suppl. 1): S120, 2001

Spontaneous operational tolerance in kidney transplant recipients. American Journal of Transplantation 12(5): 1350; Author Reply 1351-2, 2012

Characterization of spontaneous transplant tolerance exemplified by orthotopic liver transplantation: significance of Fas ligand induced programmed cell death. Langenbecks Archiv für Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft für Chirurgie. Kongress 115(Suppl I): 361-365, 1998

Immunoregulation in liver transplant recipients: possible evidence of tolerance by DTH assay. TransplantationProceedings33(1-2):1377, 2001

Analysis of clinical variables associated with tolerance in pediatric liver transplant recipients. Pediatric Transplantation 14(8): 976-979, 2010

Outcomes of spontaneous bacterial peritonitis in liver transplant recipients with allograft failure. Transplant Infectious Disease 18(4): 545-551, 2016

Tolerance and latent cellular rejection in long-term liver transplant recipients. Hepatology 28(2): 443-449, 1998

Comparison of pharmacokinetics of mycophenolic acid and its metabolites between living donor liver transplant recipients and deceased donor liver transplant recipients. Liver Transplantation 15(11): 1473-1480, 2009

Etiology and mortality of spontaneous bacterial peritonitis in liver transplant recipients: a cohort study. Liver Transplantation 20(7): 856-863, 2014

Beyond the NIH Multicenter HIV Transplant Trial Experience: Outcomes of HIV+ Liver Transplant Recipients Compared to HCV+ or HIV+/HCV+ Coinfected Recipients in the United States. Clinical Infectious Diseases 61(7): 1054-1062, 2015

Using transcriptional profiling to develop a diagnostic test of operational tolerance in liver transplant recipients. Journal of Clinical Investigation 118(8): 2845-2857, 2008

Trial of complete weaning from immunosuppression for liver transplant recipients: factors predictive of tolerance. Liver Transplantation 19(9): 937-944, 2013

Spontaneous tolerance: Experience with the rat liver transplant model. Human Immunology 63(10): 853-861, 2002

Mechanisms of murine spontaneous liver transplant tolerance. Experimental and Clinical Transplantation 12(1): 1-8, 2014